跳至主要内容
临床试验/JPRN-UMIN000003432
JPRN-UMIN000003432已完成未知

Observational study about the prognostic implication of chromosomal and genetic alterations in adult acute myeloid leukemia. -JALSG AML209 Genetic Study (AML209-GS)- - Observational study about the prognostic implication of chromosomal and genetic alterations in adult acute myeloid leukemia.

Japan adult leukemia study group0 个研究点目标入组 1,826 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,826

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.The patients who had received chemotherapy, irradiation or hematopoietic stem cell transplantation against acute leukemias of ambiguous lineage, myeloproliferative neoplasms, myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. 2.The patients with natural killer cell lymphoblastic leukemia / lymphoma. 3.The patients with active cancer. 4.The patients who developed myocardial infarction within 1 year. 5.The patients with diabetes which is uncontrollable even with insulin. 6.The patients with active infection. 7.The patients with liver cirrhosis. 8.The patients who have the past history of renal dysfunction. 9.The patients with deep vein thrombosis requiring the treatment. 10.The patients with psychological disease. 11.The women who is or may be in pregnancy. 12.The HBV antigen or HIV antibody positive patients.

研究者

相似试验